Search for: "Pharm-Save, Inc"
Results 41 - 55
of 55
Sort by Relevance
|
Sort by Date
1 Dec 2011, 9:20 am
CVS Pharm., Inc., 646 F.3d 169, the U.S. [read post]
4 Oct 2011, 3:19 pm
CVS Pharm., Inc., 646 F.3d 169 (CA-4, 2011), the U.S. [read post]
19 Sep 2011, 9:36 am
With the exception of a few evidence scholars, Federal Rule of Evidence 703 is ignored or misunderstood in practice. [read post]
18 Jul 2011, 6:12 am
Precision IBC, Inc. v. [read post]
1 Apr 2011, 5:17 pm
The test for sufficiency of a written description is "whether the disclosure clearly 'allow[s] persons of ordinary skill in the art to recognize that [the inventor] invented what is claimed.'" Ariad Pharms., Inc. v. [read post]
3 Oct 2010, 10:16 pm
Lifelock was recently voted 8th overall and #1 in security in INC Magazine's top-growing 500 companies. [read post]
13 Aug 2010, 12:46 pm
See King Pharms., Inc., 593 F. [read post]
3 May 2010, 8:03 pm
However, the court interpreted Bilski to mean that the “machine-or-transformation test” is the sole test to determine the patent eligibility of method claims.King Pharms., Inc. v. [read post]
14 Apr 2010, 12:05 pm
Circuit's March 2, 2010 decision in Teva Pharms USA, Inc. v. [read post]
2 Apr 2010, 3:31 pm
Ortho Pharm. [read post]
15 Mar 2010, 2:09 pm
Sandoz Pharm. [read post]
3 Sep 2009, 8:25 pm
Wang Labs., Inc. v. [read post]
13 Mar 2009, 4:00 am
– Need for business and government to understand role of IP (IPEG) Global - Trade Marks / Brands New record for international trade mark registrations in 2008 but signs of slowdown at year end and possible negative annual income (WIPO) (IP Frontline) (Intellectual Property Watch) (Law360) Coca-Cola is no longer the world’s most valuable brand (IAM) WTO session tackles details of future register of GI products (Intellectual Property Watch) Can a house mark or in-house… [read post]
17 Dec 2007, 4:14 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993), which requires that district courts act as "gatekeepers" concerning the admissibility of evidence - does not apply at the class certification stage. [read post]
7 Feb 2007, 4:08 am
Merrell Dow Pharm., Inc., 509 U.S. 579 (1993), which requires that district courts act as “gatekeepers” concerning the admissibility of evidence - does not apply at the class certification stage. [read post]
